Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Staar Surgical Co. Stock

Price
Target price
€42.69

€42.69

0.970%
0.41
0.970%
€49.02
 
06.05.24 / Tradegate WKN: 870353 / Symbol: STAA / Name: STAAR Surgical / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Staar Surgical Co. in the next few years
Wizard

Financial data and news for STAAR Surgical

sharewise wants to provide you with the best news and tools for STAAR Surgical, so we directly link to the best financial data sources.

Financials

News

Broker

 

News

STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel: https://mms.businesswire.com/media/20240501408389/en/2115844/5/nate_sisitsky_linkedin.jpg
STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today

BusinessWire_EN 
0 01.05.24
STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024: https://mms.businesswire.com/media/20240402599401/en/2086323/5/Image_1_STAAR_Will-Levis-Invite_1x1.jpg
STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL) for myopia, astigmatism and presbyopia, comes to

BusinessWire_EN 
0 02.04.24
STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses: https://mms.businesswire.com/media/20240318771746/en/2069563/5/EVO_-_3M_Lens_commas.jpg
STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today

BusinessWire_EN 
0 18.03.24
STAAR Surgical Announces Strategic Agreement in U.S. with SharpeVision: https://mms.businesswire.com/media/20240123947715/en/2006414/5/SV_PR4.jpg
STAAR Surgical Announces Strategic Agreement in U.S. with SharpeVision


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, and

BusinessWire_EN 
0 23.01.24
STAAR Surgical to Report First Quarter Results on May 7, 2024: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical to Report First Quarter Results on May 7, 2024


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today

BusinessWire_EN 
0 29.04.24
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today

BusinessWire_EN 
0 04.04.24
STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced

BusinessWire_EN 
0 12.03.24
STAAR Surgical to Participate in Two Upcoming Investor Conferences: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical to Participate in Two Upcoming Investor Conferences


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today

BusinessWire_EN 
0 06.03.24
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today

BusinessWire_EN 
0 26.02.24
STAAR Surgical to Report Fourth Quarter Results on February 26, 2024: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical to Report Fourth Quarter Results on February 26, 2024


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today

BusinessWire_EN 
0 19.02.24
STAAR Surgical Announces Preliminary Results for Fourth Quarter and Fiscal 2023: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical Announces Preliminary Results for Fourth Quarter and Fiscal 2023


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL) for myopia, astigmatism and presbyopia, today

BusinessWire_EN 
0 08.01.24
Lilian Zhou Appointed to STAAR Surgical Board of Directors: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
Lilian Zhou Appointed to STAAR Surgical Board of Directors


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced

BusinessWire_EN 
0 04.12.23
STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023): https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023)


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced

BusinessWire_EN 
0 15.11.23